His anesthesia provider billed medicare late. He got sent to collections for the $3,000 tab.

FHS
July 28, 2023
10:48 am

Thomas Greene had been experiencing pain in his right leg, a complication from diabetes, when doctors recommended a procedure to increase blood flow to the limb.

FDA Leaders’ Vaccination Warning; Michael Bolton’s Brain Tumor; JN.1 Now Dominant

Note that some links may require registration or subscription. FDA leaders said the nation may be at a “dangerous tipping point” due to declines in

January 9, 2024

A public health problem: The global increase in sugar-sweetened beverage consumption

The consumption of sugar-sweetened beverages (SSB) among adults from 1990 to 2018 in 185 countries.

October 5, 2023

Coherus offloads Humira biosimilar Yusimry for $40m

Coherus’ Yusimry was first approved in 2021 and is the seventh FDA-approved Humira biosimilar and Image Credit: Michael Vi / Shutterstock. Coherus BioSciences has divested

June 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.